Related Experiment Video
Updated: Aug 9, 2026

10:59
Human Blastocyst Biopsy and Vitrification
Published on: July 26, 2019
Embryo quality in natural versus stimulated IVF cycles
S Ziebe1, S Bangsbøll, K L T Schmidt
1The Fertility Clinic, Rigshospitalet, University Hospital of Copenhagen Section 4071, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. sziebe@rh.dk
Human Reproduction (Oxford, England)
|April 24, 2004
Summary
Controlled ovarian stimulation (COS) did not impact embryo quality compared to natural cycles. This study found no significant differences in embryo cleavage or quality scores between stimulated and natural cycles in the same patients.
Area of Science:
- Reproductive Medicine
- In Vitro Fertilization (IVF)
- Embryology
Background:
- The effect of controlled ovarian stimulation (COS) on oocyte and embryo quality is debated.
- This study directly compares embryo quality in natural versus stimulated cycles within the same patients.
Purpose of the Study:
- To compare embryo quality between natural and stimulated cycles in patients undergoing IVF.
- To investigate if exogenous gonadotropins used in COS affect subsequent embryo development and quality.
Main Methods:
- Retrospective analysis of patients with regular cycles undergoing IVF with COS (rFSH, GnRH agonist protocol).
- Comparison of embryo quality (cleavage stage, cell number, fragmentation) between fresh embryos from stimulated cycles and embryos from modified natural cycles (mFER).
Main Results:
- No significant difference in embryo cleavage rates (70.4% stimulated vs. 66.4% natural).
- Similar distribution of cleavage stages and embryo cell numbers (>=4 cells) after 2 days of culture.
- No significant difference in embryo fragmentation (<10%) at day 2 transfer (61% stimulated vs. 69% natural).
Conclusions:
- Controlled ovarian stimulation (COS) using exogenous gonadotropins does not appear to negatively impact embryo cleavage capacity or quality.
- Embryo quality assessment showed no significant differences between stimulated and natural cycles in the same patient cohort.

